Game Over for Allos in 2nd half 2011 - SGN 35 will beat all PTCL drugs

For those of you wondering why ALTH is down since the JP Morgan conference last week where we announced "blow out" Q4 sales......

listend to this Seattle Genetics audio feed around minute 15:20. This explains how and why CTCL and more PTCL subtypes than ALCL will be treated first with SGN 35.

http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink.php?ticker=SGEN

Look at the comparison of SGEN and ALTH in the last week.

All the good people from ALTH CSS and RBDs have already been contacted or soon will be.

Payors want a drug like this with 75-80% response rates where they can select patients (CS30+).

Game over Burns........I guess this is why you are trying like hell to sell Allos before the Q3 2011 FDA approved for SGN 35.

 

Re: Game Over for Allos

The company is finished.

JCO is a great peer reviewed journal and evidently we have agreed to run more ads to bribe the editors to place Propel data in 2011. No patients tolerate the 30mg dose and very few can complete a full 6 dose cycle. Did no one see the poster presentation at ASH? I guess shoving a poster in a dimly lit corner with another 1000 other posters didnt due us justice?

Its embarassing to consider this a press release. Got to get the hell off this sinking ship

 

Re: Game Over for Allos

Everyone knows that Celgene was interested in buying us before we launched in 2009. They took a look at the data and passed. My guess is that celgene was unimpressed with Burns and his sole desire to sell the company hell that was when the stock was $8 per share. The jig is up, we are forced to rehash old data, cut personnel, cut clinical trials, and this is supposed to be good news? $3 per share he we come

C

 

A couple of the RD's are about to jump ship. Any one care to take quesses on who it may be?

 

The fuse has been lit.

 

talentless douchebags

 

We are going to see $2 per share before we see $5. Once again no one can tolerate drug and management is tone deaf to reality.